These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26393387)

  • 1. Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.
    Arabyat RM; Raisch DW; McKoy JM; Bennett CL
    Expert Opin Drug Saf; 2015; 14(11):1653-60. PubMed ID: 26393387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population.
    Seeger JD; West WA; Fife D; Noel GJ; Johnson LN; Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):784-92. PubMed ID: 16456878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis.
    Ali AK
    Ann Epidemiol; 2014 Apr; 24(4):279-85. PubMed ID: 24472364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database.
    Shu Y; Zhang Q; He X; Liu Y; Wu P; Chen L
    Front Pharmacol; 2022; 13():990241. PubMed ID: 36147351
    [No Abstract]   [Full Text] [Related]  

  • 5. Signal mining and analysis for central nervous system adverse events due to taking oxycodone based on FAERS database.
    Wu X; Zhang L; Huang H; Huang L; Lu X; Wang Z; Xiao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):422-434. PubMed ID: 37164926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature.
    Raisch DW; Garg V; Arabyat R; Shen X; Edwards BJ; Miller FH; McKoy JM; Nardone B; West DP
    Expert Opin Drug Saf; 2014 Jan; 13(1):15-23. PubMed ID: 24053773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musculoskeletal injury associated with fluoroquinolone antibiotics.
    Khaliq Y; Zhanel GG
    Clin Plast Surg; 2005 Oct; 32(4):495-502, vi. PubMed ID: 16139623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of the association between fluoroquinolones and tendon rupture: The magnitude of the effect with and without corticosteroids.
    Persson R; Jick S
    Br J Clin Pharmacol; 2019 May; 85(5):949-959. PubMed ID: 30682225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study.
    Morales DR; Slattery J; Pacurariu A; Pinheiro L; McGettigan P; Kurz X
    Clin Drug Investig; 2019 Feb; 39(2):205-213. PubMed ID: 30465300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system.
    Meng L; Huang J; Jia Y; Huang H; Qiu F; Sun S
    Int J Clin Pract; 2019 May; 73(5):e13331. PubMed ID: 30809871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluorquinolone associated tendon rupture].
    Rätz Bravo A; Stoll R; Bürr P; Haschke M
    Praxis (Bern 1994); 2008 Nov; 97(22):1159-67. PubMed ID: 18979434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study.
    Ali AK; Heran BS; Etminan M
    Pharmacotherapy; 2015 Jul; 35(7):687-95. PubMed ID: 26133534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?
    Bidell MR; Lodise TP
    Pharmacotherapy; 2016 Jun; 36(6):679-93. PubMed ID: 27138564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors.
    Verden A; Dimbil M; Kyle R; Overstreet B; Hoffman KB
    Drug Saf; 2018 Apr; 41(4):357-361. PubMed ID: 29196988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.
    Garg V; Raisch DW; McKoy JM; Trifilio SM; Holbrook J; Edwards BJ; Belknap SM; Samaras AT; Nardone B; West DP
    Expert Opin Drug Saf; 2013 May; 12(3):299-307. PubMed ID: 23480866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of fluoroquinolone-induced tendon disorders using a hospital database in Japan.
    Hori K; Yamakawa K; Yoshida N; Ohnishi K; Kawakami J
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):886-9. PubMed ID: 22532516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010-2019.
    Setyawan J; Azimi N; Strand V; Yarur A; Fridman M
    Drug Saf; 2021 Aug; 44(8):889-897. PubMed ID: 34120321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
    Huruba M; Farcas A; Leucuta DC; Bucsa C; Sipos M; Mogosan C
    Sci Rep; 2021 Jul; 11(1):14375. PubMed ID: 34257376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Tendon Injury in Patients Treated With Fluoroquinolone (FQ) Versus Non-Fluoroquinolone Antibiotics for Community-Acquired Pneumonia (CAP).
    Fleming VH; Xu J; Chen X; Hall D; Southwood RL
    Ann Pharmacother; 2024 Aug; 58(8):771-780. PubMed ID: 37946374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.
    Jones SC; Sorbello A; Boucher RM
    Drug Saf; 2011 Oct; 34(10):839-47. PubMed ID: 21879778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.